Verrunex label

Verrunex

Verrunex Recall

Get an alert when a recall is issued.

Add Info

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

There is currently no usage information available for this product. We apologize for any inconvenience.

Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

VERRUNEX® is comprised of 0.5 g of Fluorouracil USP and 1.2 g of Salicylic Acid USP, for dermatological use.1 VERRUNEX® also contains a Cream Base containing purified water, white petrolatum, sorbitol solution, cetearyl alcohol, propylene glycol, ceteareth-20, simethicone, glyceryl monostearate, polyethylene glycol monostearate, sorbic acid and BHT. When mixed as instructed, the final product provides a homogeneous cream mixture containing Fluorouracil, and Salicylic Acid comparable to the active ingredients (Efudex® 5% and Compound W® 17%) contained in VERRUNEX®.2

1
Certificate of analysis on file
2
This product is not manufactured by Valeant Pharmaceuticals, manufacturer of Efudex®, or by Prestige Brands Inc., manufacturer of Compound W®.
Add Info
Add to My Alerts
Report Side Effect
Leave a Review
Navigate to :
Verrunex Recall
Side Effects & Adverse Reactions
Legal Issues
FDA Safety Alerts
Manufacturer Warnings
FDA Labeling Changes
Uses
History
Other Information
Manufacturers
Trending Topics

Verrunex Manufacturers

  • Accumix Pharmaceuticals
    Verrunex | Accumix Pharmaceuticals
    No Recall

    Verrunex | Accumix Pharmaceuticals

    Verrunex | Accumix Pharmaceuticals

    The pharmacist must mix contents of each container with appropriate amount of Cream Base yielding a final volume of 10 grams at the time of dispensing. Pharmacist may utilize appropriate diluents if needed from the respective active component Material Safety Data Sheet only. For dermatological use only. This product should not be administered orally, intravaginally or into the eyes.

    CAUTION: Observe and exercise appropriate precautions for handling, preparing, and administering cytotoxic drugs.

Login To Your Free Account